CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)
Publication
, Journal Article
Bireley, JD; Morren, JA
Published in: Expert Opinion on Investigational Drugs
August 3, 2023
Duke Scholars
Published In
Expert Opinion on Investigational Drugs
DOI
EISSN
1744-7658
ISSN
1354-3784
Publication Date
August 3, 2023
Volume
32
Issue
8
Start / End Page
677 / 683
Publisher
Informa UK Limited
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bireley, J. D., & Morren, J. A. (2023). CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS). Expert Opinion on Investigational Drugs, 32(8), 677–683. https://doi.org/10.1080/13543784.2023.2252738
Bireley, J Daniel, and John A. Morren. “CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS).” Expert Opinion on Investigational Drugs 32, no. 8 (August 3, 2023): 677–83. https://doi.org/10.1080/13543784.2023.2252738.
Bireley JD, Morren JA. CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS). Expert Opinion on Investigational Drugs. 2023 Aug 3;32(8):677–83.
Bireley, J. Daniel, and John A. Morren. “CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS).” Expert Opinion on Investigational Drugs, vol. 32, no. 8, Informa UK Limited, Aug. 2023, pp. 677–83. Crossref, doi:10.1080/13543784.2023.2252738.
Bireley JD, Morren JA. CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS). Expert Opinion on Investigational Drugs. Informa UK Limited; 2023 Aug 3;32(8):677–683.
Published In
Expert Opinion on Investigational Drugs
DOI
EISSN
1744-7658
ISSN
1354-3784
Publication Date
August 3, 2023
Volume
32
Issue
8
Start / End Page
677 / 683
Publisher
Informa UK Limited
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences